United States v. Nysco Laboratories, Inc., 60-C-530.
Decision Date | 04 March 1963 |
Docket Number | No. 60-C-530.,60-C-530. |
Citation | 215 F. Supp. 87 |
Parties | UNITED STATES of America, Plaintiff, v. NYSCO LABORATORIES, INC., a corporation, and Eugene J. Yoss, an individual, Defendants. |
Court | U.S. District Court — Eastern District of New York |
Joseph P. Hoey, U. S. Atty., Eastern Dist. of New York, for plaintiff; Martin R. Pollner, Asst. U. S. Atty., of counsel.
Bass & Friend, New York City, for defendants; Solomon H. Friend, New York City, of counsel.
The plaintiff moves for summary judgment.
This action was instituted, pursuant to 21 U.S.C. § 321 et sequa, to enjoin the defendant corporation and its president, Eugene J. Yoss, and those in participation with them from introducing into interstate commerce a certain drug containing phenylpropanolamine hydrochloride. The plaintiff, in its complaint, alleges that the labeling, accompanying the drug, represents and suggests that it is adequate and effective in weight reduction and control by curbing the appetite, as an adjunct in the control of obesity and that such statements are false and misleading.
The statutes, 21 U.S.C. §§ 321, 331, 332 (a) and 502 empower the appropriate district court to grant an injunction against false or misleading labeling of drugs. Such labeling is termed misbranding.
Approximately twelve in rem actions were instituted by the Government in various district courts for the seizure and forfeiture of large quantities of the drug located within those jurisdictions. Pursuant to the libels, the drugs were seized by and now are in the possession of the Marshals. All of the cases were transferred to the District Court of New Jersey for disposition. The case of United States v. 60 28-Capsule Bottles, etc., Unitrol, D.C., 211 F.Supp. 207 was chosen as being representative of the others and tried before Judge Thomas F. Meaney. The defendant, Nysco Laboratories, Inc., appeared as the claimant therein. Judge Meaney wrote a lengthy opinion, containing findings, followed by judgment dated January 22, 1963. Included therein are the following provisions:
Undoubtedly the granting of the stay against destruction of the drug was to preserve the claimant's right of appeal, otherwise it would have been rendered moot. See United States v. 3 Unlabeled, etc., Dried Mushrooms, 7 Cir., 157 F.2d 722.
The said judgment has the effect of an injunction, restraining the claimant from distributing and marketing the seized drugs. As previously mentioned, those drugs remain in the possession of the Marshals.
The plaintiff contends that the said determination in the New Jersey court is res adjudicata of the issues in the subject action.
The claimant in the New Jersey action is Nysco Laboratories Inc., hereinafter called the Corporation. The defendants in the subject action are the Corporation and its president, Eugene J. Yoss. They admit that he is the president and has a voice in the policies and activities of the Corporation. (Par. 3 of the answer)
The Corporation in its answer admitted the allegations in paragraph 4 of the complaint, viz.:
"Said defendants have been and are now engaged in the business of manufacturing, packaging, labeling, selling and distributing in interstate commerce, articles of drug consisting of timed disintegration capsules containing 75 milligrams of phenylpropanolamine hydrochloride, timed disintegration capsules containing 50 milligrams of phenylpropanolamine hydrochloride, a straight 25 miligram tablet of phenylpropanolamine hydrochloride, chewing gum containing 25 milligrams of phenylpropanolamine hydrochloride, and a capsule containing phenylpropanolamine hydrochloride combined with vitamins and minerals."
The defendants admit that the labeling, alleged in paragraph 5(c) of the complaint is part of the labeling they use for the drugs. The paragraph is lengthy. A portion thereof is quoted, viz.:
To continue reading
Request your trial-
Neeld v. National Hockey League
...Huron Holding Corp. v. Lincoln Mine Operating Co., 312 U.S. 183, 188-89, 61 S.Ct. 513, 85 L.Ed. 725 (1941); United States v. Nysco Laboratories, Inc., 215 F.Supp. 87, 89 (E.D.N.Y.), aff'd, 318 F.2d 817 (2d Cir. 5 In Baltimore S. S. Co. v. Phillips, 274 U.S. 316, 321, 47 S.Ct. 600, 602, 71 L......
-
Cerbone v. County of Westchester
...League, 439 F.Supp. 446, 450 n.4 (W.D.N.Y. 1977); Rodriguez v. Beame, 423 F.Supp. 906, 908 (S.D.N.Y.1976); United States v. Nysco Laboratories, Inc., 215 F.Supp. 87, 89 (E.D.N. Y.), aff'd, 318 F.2d 817 (2d Cir. 1963); International Carrier-Call & Television Corp. v. Radio Corp. of Amer., 51......
-
Antonious v. Muhammad
...288, 292 (2d Cir.1990); Fidelity Mortg. Inv. v. First Nat'l City Bank, 387 F.Supp. 544, 550-51 (S.D.N.Y.1974); United States v. Nysco Labs., Inc., 215 F.Supp. 87, 89 (E.D.N.Y.), aff'd, 318 F.2d 817, 818 (2d ...
-
United States v. Diapulse Corporation of America
...v. Article of Drug . . . Designated . . . B-Complex Cholinos Capsules, 362 F.2d 923, 928 (3d Cir. 1966); see United States v. Nysco Laboratories, Inc., 215 F.Supp. 87 (E.D.N.Y.), aff'd 318 F.2d 817 (2d Cir. 1963). The injunction may sweep broadly in its prohibition if that is necessary to e......